Pearson

03/05/21 -"We have slightly raised our target price following what we judge as an encouraging Q1 21 trading update (please refer to our 26/04/2021 Latest). Going forward, vaccination, which has been strong in ..."

PDF page sample
Pages
53
Language
English
Published on
03/05/21
Download
You may also be interested by these reports :
14/11/25
MFE launched an offer in March at €5.75 per share, later increasing it to €8 (€4.45 in cash and the remainder in MFE shares). On 4 September, MFE ...
14/11/25
Wolters Kluwer announced a relatively small acquisition to reinforce its GenAI capabilities in legal. We think this is a smart acquisition as the ...
12/11/25
Informa delivered a good 10-month trading update, reaffirming its guidance for FY25 ahead of its CMD next week. The interesting news from this press ...
10/11/25
The revision of the target price reflects updates to EPS forecasts, as well as NAV and DCF adjustments. WPP faces a challenging situation, with ...

EXECUTIVE SUMMARY

Updates Pension Risks
Target & Opinion Governance & Management
Business & Trends Graphics : Momentum
Money Making Graphics : MACD & Volumes
Debt Graphics : Sensitivities
Valuation Sector: Performance
DCF Sector: Key data
NAV/SOTP Sector: Ratios & Valorisation
Worth knowing Sector: Peers
Financials Sector: Analysis

CONFLICTS OF INTEREST

AlphaValue does not have nor seek any business with companies covered in AlphaValue Research paid by subscription. As a result, investors can be confident that there is no conflict of interest that could affect the objectivity of AlphaValue Research.

Corporate broking NO
Trading in corporate shares NO
Analyst ownership NO
Advising of corporate (strategy, marketing, debt, etc) NO
Research paid for by corporate NO
Provision of corporate access paid for by corporate NO
Link between and a banking entity NO
Brokerage activity at AlphaValue NO